Euronoxx Medical Group

The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), recently unveiled the latest evaluations of the global burden of cancer. These estimates are based on a comprehensive encyclopedic overview of the world's countries in 2022. They shed light on the escalating challenge posed by cancer, particularly highlighting its inequitable impact on vulnerable populations. Globally cancer remains a formidable adversary, the figures from 2022 highlighting a stark picture. It is counted that there were 20 million recent cases of cancer and 9.7 million cancer-related deaths. The statistics further reveal that 53.5 million individuals were living within five years of a cancer diagnosis, indicating the enduring impact and survivorship journey that comes with combating cancer. One alarming statistic that stands out is that approximately 1 in 7 in the UK population will confront a breast cancer diagnosis in their lifetime. The burden of br...

Breast cancer continues to pose a significant global health challenge, with 2021 marking a diagnostic manoeuvre as it surpassed lung cancer to become the most frequently diagnosed cancer worldwide, particularly impacting women. Faced with this hindrance, effective breast cancer screening has emerged as a crucial tool in early detection, ultimately leading to improved patient outcomes. Breast Cancer Screening : Clinical Decision-Making! The implementation of population-based breast cancer screening programs in developed countries has played a vital role in reducing mortality rates and instances of advanced cancer. As a result, the need for comprehensive breast cancer screening guidelines has become increasingly apparent, providing clinicians with valuable resources for informed decision-making based on thorough evidence-based reviews and recommendations. Several developed countries have issued their own breast cancer screening guidelines, each accommodating their resp...

Breast cancer is the most prevalent type of cancer in women, and the significance of early detection cannot be overstated. With the multitude of screening options available, it can be overwhelming for women to decide on the most effective method.  Two leading screening methods, Koning Vera Breast CT screening and mammogram test , have been at the forefront of discussions on early detection.  Let’s investigate the details of these options and why women should carefully consider their choices. First things first, understanding the statistics surrounding breast cancer is crucial. In the UK, the anticipated number of new cases of invasive breast cancer in women for 2021 is alarming, and the mortality rates serve as a sombre reminder of the urgency of effective screening methods.  "The lifetime diagnosis rate for breast cancer in UK females is 1 out of 7". The effectiveness of regular screening in reducing mortality by 40% cannot be overlooke...

Breast cancer is a pervasive breast disease that has impacted millions of women worldwide, leading to significant morbidity and mortality.  While progress has been made in the field of breast cancer treatment, early detection remains one of the most effective strategies for improving patient outcomes. In recent years, there has been growing interest in the use of KoningCT breast imaging procedures to screen for breast cancer. Evidence shows that skipping these procedures could increase the risk of breast cancer death. Traditionally, mammography has been the primary screening method for breast cancer ! However, concerns regarding the accuracy of mammography have led to the development of alternative screening modalities, including Koning CT breast imaging procedures. These procedures use cone-beam computed tomography technology to image the breast and detect abnormalities that may indicate the presence of breast cancer. Research shows that failing to undergo bre...

The Radiological Society of North America (RSNA) 2023 in their Annual Meeting venerated for its advanced educational courses, science congress, conduits for information, and technical manifest, set the stage for a major breakthrough in peer-reviewed radiology.  Koning Health, a frontrunner in innovative healthcare technology, seized the spotlight at the RSNA 2023 with its groundbreaking product, the Koning BreastCT . Koning's Revolutionary Breakthrough at RSNA 2023! Amidst the science congress of thousands of professionals, the RSNA 2023 meeting emerged as a platform for showcasing technological advancements through applied research in radiology, offering over 400 educational and scientific congress.  Amidst this wealth of innovation, Koning Breast CT Patient Monitoring Laboratory Equipment made waves by introducing the FDA PMA-approved Koning VeraBreast CT (KBCT), marking a revolution in breast CT technology.  Koning Breast CT Med...

Breast cancer is a disease that affects millions of women globally and has become a leading cause of cancerous morbidity and mortality. In 2022, breast cancer caused 670,000 deaths among 2.3 million diagnosed women worldwide. It signifies a woman is diagnosed with breast cancer every 14 seconds. Every woman is at some risk for breast cancer, but the degree of risk varies from very low to very high. Understanding one's risk is crucial as it can affect important medical decisions and the course of treatment.  Additionally, it's important to be aware of the possibility of breast cancer recurrence, which can happen even after initial treatment.  In this discussion, we will explore real case studies and the concept of breast cancer risk, the importance of early detection, and what it means to experience breast cancer recurrence. Understanding Breast Cancer Risk and Recurrence: A Guide for Women! Breast cancer risk is a unique challenge to reverse, and...